Logo image of KZIA

KAZIA THERAPEUTICS-SPON ADR (KZIA) Stock Analyst Earnings Estimates

NASDAQ:KZIA - Nasdaq - US48669G3039 - ADR - Currency: USD

8.34  +0.16 (+1.96%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
KZIA revenue by date.KZIA revenue by date.
2.1K
-99.99%
22.6K
976.19%
2.32M
10,165.49%
34.17K
-98.53%
51K
49.25%
31.11K
-39.00%

-100.00%
45.498M90.135M
98.11%
148.97M
65.27%
217.33M
45.89%
EBITDA
YoY % growth
KZIA ebitda by date.KZIA ebitda by date.
N/A
-1,735.97%
N/A
-9.90%
N/A
124.14%
7.2M
16.50%
N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
KZIA ebit by date.KZIA ebit by date.
-25.382M
-300.46%
-24.125M
4.95%
-27.193M
-12.72%
-36.685M
-34.91%
-41.408M
-12.87%
-44.363M
-7.14%
-46.03M
-3.76%
427.168K
100.93%
53.94M
12,527.34%
112.42M
108.42%
173.51M
54.34%
Operating Margin
KZIA operating margin by date.KZIA operating margin by date.
-1,208,671.43%-106,745.58%-1,172.11%-107,361.19%-81,192.00%-142,600.00%N/A0.94%59.84%75.46%79.84%
EPS
YoY % growth
KZIA eps by date.KZIA eps by date.
N/A
-8,174.48%
N/A
89.43%
N/A
100.20%
-26.52
-236,463.64%
-12.95
51.15%
-10.05
22.44%
-8.93
11.14%
0.10
101.10%
9.91
9,951.91%
20.47
106.47%
31.32
53.01%

All data in AUD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q2 / 26 Q4 / 26
EPS
Q2Q % growth
-11.27-6.89
44.02%
-6.12
45.70%
Revenue
Q2Q % growth
8.16K
-99.65%

-100.00%
EBITDA
Q2Q % growth
N/AN/AN/A
EBIT
Q2Q % growth
-16.607M
10.59%
-19.876M
-29.05%
-21.532M
-29.66%

All data in AUD

Recent Earnings VS Estimates Surprises (AUD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-12.30 -17.445.1429.48%
Q4 2023
Q2Q % growth
-9.50
78.19%
-2.55-6.95-272.55%
Q4 2022
Q2Q % growth
-43.55 -5.10-38.45-753.92%
Q2 2021
Q2Q % growth
-29.50
-23,080.89%
-3.06-26.44-864.05%
Q2 2020
Q2Q % growth

49.80%
-0.13%
KZIA Yearly EPS VS EstimatesKZIA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -50 -100
Recent Revenue VS Estimates Surprises (AUD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth

-100.00%
%
Q2 2024
Q2Q % growth
6.5K
6,400.00%
%
Q4 2023
Q2Q % growth
22.4K
-100.00%
23.46K-23.46K-100.00%
Q2 2023
Q2Q % growth
100
-95.00%
%
Q4 2022
Q2Q % growth
100
-100.00%
518.16K-518.06K-99.98%
Q2 2022
Q2Q % growth
2K
-93.51%
%
Q4 2021
Q2Q % growth
15.194M
45,527.93%
%
Q2 2021
Q2Q % growth
30.8K
-5.52%
612K-581.2K-94.97%
Q4 2020
Q2Q % growth
33.3K
-66.57%
%
Q2 2020
Q2Q % growth
32.6K
13.19%
1.522M-1.49M-97.86%
Q2 2019
Q2Q % growth
28.8K 3.12M-3.091M-99.08%
KZIA Yearly Revenue VS EstimatesKZIA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 2030 2031 2032 50M 100M 150M 200M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 0%
RevenueN/A N/A N/A N/A